Short Bowel Syndrome (SBS) Drugs Market Report

Global and Region Short Bowel Syndrome (SBS) Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：236
  • REPORT CODE：GMM913417
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Short Bowel Syndrome (SBS) Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Short Bowel Syndrome (SBS) Drugsmarket, defines the market attractiveness level of Short Bowel Syndrome (SBS) Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Short Bowel Syndrome (SBS) Drugs industry, describes the types of Short Bowel Syndrome (SBS) Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Short Bowel Syndrome (SBS) Drugs market and the development prospects and opportunities of Short Bowel Syndrome (SBS) Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Short Bowel Syndrome (SBS) Drugs market in Chapter 13.

    By Player:

    • Zealand Pharma

    • OxThera

    • Emmaus Medical

    • Nutrinia

    • Naia Pharmaceuticals

    • Merck

    • Sancilio Pharmaceuticals

    • Ardelyx

    • Shire

    By Type:

    • Glucagon-Like Peptide-2 (GLP-2)

    • Growth Hormone

    • Glutamine

    • Other

    By End-User:

    • Hospitals

    • Clinics

    • Retail Pharmacies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Short Bowel Syndrome (SBS) Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Short Bowel Syndrome (SBS) Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Short Bowel Syndrome (SBS) Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Short Bowel Syndrome (SBS) Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Short Bowel Syndrome (SBS) Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Short Bowel Syndrome (SBS) Drugs Consumption (2017-2022)

    • 7.2 United States Short Bowel Syndrome (SBS) Drugs Consumption (2017-2022)

    • 7.3 Europe Short Bowel Syndrome (SBS) Drugs Consumption (2017-2022)

    • 7.4 China Short Bowel Syndrome (SBS) Drugs Consumption (2017-2022)

    • 7.5 Japan Short Bowel Syndrome (SBS) Drugs Consumption (2017-2022)

    • 7.6 India Short Bowel Syndrome (SBS) Drugs Consumption (2017-2022)

    • 7.7 South Korea Short Bowel Syndrome (SBS) Drugs Consumption (2017-2022)

    8 Region and Country-wise Short Bowel Syndrome (SBS) Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Short Bowel Syndrome (SBS) Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Short Bowel Syndrome (SBS) Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Short Bowel Syndrome (SBS) Drugs Consumption Forecast (2022-2028)

    • 8.4 China Short Bowel Syndrome (SBS) Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Short Bowel Syndrome (SBS) Drugs Consumption Forecast (2022-2028)

    • 8.6 India Short Bowel Syndrome (SBS) Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Short Bowel Syndrome (SBS) Drugs Consumption Forecast (2022-2028)

    9 Global Short Bowel Syndrome (SBS) Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Short Bowel Syndrome (SBS) Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Glucagon-Like Peptide-2 (GLP-2) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Growth Hormone Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Glutamine Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Short Bowel Syndrome (SBS) Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    10 Global Short Bowel Syndrome (SBS) Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Short Bowel Syndrome (SBS) Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Glucagon-Like Peptide-2 (GLP-2) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Growth Hormone Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Glutamine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Short Bowel Syndrome (SBS) Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Short Bowel Syndrome (SBS) Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Short Bowel Syndrome (SBS) Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Short Bowel Syndrome (SBS) Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Short Bowel Syndrome (SBS) Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Short Bowel Syndrome (SBS) Drugs Market Competitive Analysis

    • 14.1 Zealand Pharma

      • 14.1.1 Zealand Pharma Company Details

      • 14.1.2 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product and Service

    • 14.2 OxThera

      • 14.2.1 OxThera Company Details

      • 14.2.2 OxThera Short Bowel Syndrome (SBS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 OxThera Short Bowel Syndrome (SBS) Drugs Product and Service

    • 14.3 Emmaus Medical

      • 14.3.1 Emmaus Medical Company Details

      • 14.3.2 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product and Service

    • 14.4 Nutrinia

      • 14.4.1 Nutrinia Company Details

      • 14.4.2 Nutrinia Short Bowel Syndrome (SBS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Nutrinia Short Bowel Syndrome (SBS) Drugs Product and Service

    • 14.5 Naia Pharmaceuticals

      • 14.5.1 Naia Pharmaceuticals Company Details

      • 14.5.2 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product and Service

    • 14.6 Merck

      • 14.6.1 Merck Company Details

      • 14.6.2 Merck Short Bowel Syndrome (SBS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Merck Short Bowel Syndrome (SBS) Drugs Product and Service

    • 14.7 Sancilio Pharmaceuticals

      • 14.7.1 Sancilio Pharmaceuticals Company Details

      • 14.7.2 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product and Service

    • 14.8 Ardelyx

      • 14.8.1 Ardelyx Company Details

      • 14.8.2 Ardelyx Short Bowel Syndrome (SBS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Ardelyx Short Bowel Syndrome (SBS) Drugs Product and Service

    • 14.9 Shire

      • 14.9.1 Shire Company Details

      • 14.9.2 Shire Short Bowel Syndrome (SBS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Shire Short Bowel Syndrome (SBS) Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Short Bowel Syndrome (SBS) Drugs

    • Figure Short Bowel Syndrome (SBS) Drugs Picture

    • Table Global Short Bowel Syndrome (SBS) Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Short Bowel Syndrome (SBS) Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Short Bowel Syndrome (SBS) Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Short Bowel Syndrome (SBS) Drugs Consumption by Country (2017-2022)

    • Figure United States Short Bowel Syndrome (SBS) Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Short Bowel Syndrome (SBS) Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Short Bowel Syndrome (SBS) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Short Bowel Syndrome (SBS) Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Short Bowel Syndrome (SBS) Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Short Bowel Syndrome (SBS) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Short Bowel Syndrome (SBS) Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Short Bowel Syndrome (SBS) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Short Bowel Syndrome (SBS) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Short Bowel Syndrome (SBS) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Short Bowel Syndrome (SBS) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Short Bowel Syndrome (SBS) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Short Bowel Syndrome (SBS) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Glucagon-Like Peptide-2 (GLP-2) Consumption and Growth Rate (2017-2022)

    • Figure Global Growth Hormone Consumption and Growth Rate (2017-2022)

    • Figure Global Glutamine Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Glucagon-Like Peptide-2 (GLP-2) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Growth Hormone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Glutamine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Short Bowel Syndrome (SBS) Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Short Bowel Syndrome (SBS) Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Zealand Pharma (Foundation Year, Company Profile and etc.)

    • Table Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product and Service

    • Table OxThera (Foundation Year, Company Profile and etc.)

    • Table OxThera Short Bowel Syndrome (SBS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table OxThera Short Bowel Syndrome (SBS) Drugs Product and Service

    • Table Emmaus Medical (Foundation Year, Company Profile and etc.)

    • Table Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product and Service

    • Table Nutrinia (Foundation Year, Company Profile and etc.)

    • Table Nutrinia Short Bowel Syndrome (SBS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nutrinia Short Bowel Syndrome (SBS) Drugs Product and Service

    • Table Naia Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Short Bowel Syndrome (SBS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Short Bowel Syndrome (SBS) Drugs Product and Service

    • Table Sancilio Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product and Service

    • Table Ardelyx (Foundation Year, Company Profile and etc.)

    • Table Ardelyx Short Bowel Syndrome (SBS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ardelyx Short Bowel Syndrome (SBS) Drugs Product and Service

    • Table Shire (Foundation Year, Company Profile and etc.)

    • Table Shire Short Bowel Syndrome (SBS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire Short Bowel Syndrome (SBS) Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US